Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23592359JP XVII Ultraviolet-visible Reference Spectra

Oxytocin

Ozagrel Sodium

Panipenem

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23602360 JP XVIIUltraviolet-visible Reference Spectra

Paroxetine Hydrochloride Hydrate

Pemirolast Potassium

Penbutolol Sulfate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23612361JP XVII Ultraviolet-visible Reference Spectra

Pentazocine

Peplomycin Sulfate

Perphenazine 1

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23622362 JP XVIIUltraviolet-visible Reference Spectra

Perphenazine 2

Perphenazine Maleate 1

Perphenazine Maleate 2

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23632363JP XVII Ultraviolet-visible Reference Spectra

Pethidine Hydrochloride

Phenethicillin Potassium

Phenobarbital

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23642364 JP XVIIUltraviolet-visible Reference Spectra

Phenolsulfonphthalein

Phenylbutazone

Phytonadione 1

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23652365JP XVII Ultraviolet-visible Reference Spectra

Phytonadione 2

Pilsicainide Hydrochloride Hydrate

Pimaricin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23662366 JP XVIIUltraviolet-visible Reference Spectra

Pimozide

Pindolol

Pioglitazone Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23672367JP XVII Ultraviolet-visible Reference Spectra

Pipemidic Acid Hydrate

Pirarubicin

Pirenoxine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23682368 JP XVIIUltraviolet-visible Reference Spectra

Pirenzepine Hydrochloride Hydrate

Piroxicam

Pitavastatin Calcium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23692369JP XVII Ultraviolet-visible Reference Spectra

Potassium Canrenoate

Potassium Clavulanate

Potassium Guaiacolsulfonate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23702370 JP XVIIUltraviolet-visible Reference Spectra

Pranlukast Hydrate

Pranoprofen

Pravastatin Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23712371JP XVII Ultraviolet-visible Reference Spectra

Prazepam

Prazosin Hydrochloride

Prednisolone Sodium Phosphate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23722372 JP XVIIUltraviolet-visible Reference Spectra

Probenecid

Probucol

Procaine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23732373JP XVII Ultraviolet-visible Reference Spectra

Procarbazine Hydrochloride

Procaterol Hydrochloride Hydrate

Progesterone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23742374 JP XVIIUltraviolet-visible Reference Spectra

Promethazine Hydrochloride

Propafenone Hydrochloride

Propiverine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23752375JP XVII Ultraviolet-visible Reference Spectra

Propranolol Hydrochloride

Pyrantel Pamoate

Pyrazinamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23762376 JP XVIIUltraviolet-visible Reference Spectra

Pyridostigmine Bromide

Pyridoxine Hydrochloride

Pyrrolnitrin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23772377JP XVII Ultraviolet-visible Reference Spectra

Quetiapine Fumarate

Quinapril Hydrochloride

Quinine Ethyl Carbonate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23782378 JP XVIIUltraviolet-visible Reference Spectra

Quinine Sulfate Hydrate

Rabeprazole Sodium

Ranitidine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23792379JP XVII Ultraviolet-visible Reference Spectra

Rebamipide

Reserpine

Ribavirin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23802380 JP XVIIUltraviolet-visible Reference Spectra

Riboflavin

Riboflavin Butyrate

Riboflavin Sodium Phosphate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23812381JP XVII Ultraviolet-visible Reference Spectra

Rifampicin

Risperidone

Ritodrine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23822382 JP XVIIUltraviolet-visible Reference Spectra

Rokitamycin

Roxatidine Acetate Hydrochloride

Salazosulfapyridine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23832383JP XVII Ultraviolet-visible Reference Spectra

Salbutamol Sulfate

Salicylic Acid

Santonin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23842384 JP XVIIUltraviolet-visible Reference Spectra

Sarpogrelate Hydrochloride

Scopolamine Butylbromide

Silodosin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23852385JP XVII Ultraviolet-visible Reference Spectra

Simvastatin

Sivelestat Sodium Hydrate

Sodium Cromoglicate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23862386 JP XVIIUltraviolet-visible Reference Spectra

Sodium Picosulfate Hydrate

Sodium Risedronate Hydrate

Spiramycin Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23872387JP XVII Ultraviolet-visible Reference Spectra

Spironolactone

Sulindac

Sulpiride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23882388 JP XVIIUltraviolet-visible Reference Spectra

Sultiame

Tacalcitol Hydrate

Tamoxifen Citrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23892389JP XVII Ultraviolet-visible Reference Spectra

Tamsulosin Hydrochloride

Tegafur

Telmisartan

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23902390 JP XVIIUltraviolet-visible Reference Spectra

Temocapril Hydrochloride

Terbinafine Hydrochloride

Terbutaline Sulfate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23912391JP XVII Ultraviolet-visible Reference Spectra

Testosterone Propionate

Tetracaine Hydrochloride

Tetracycline Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23922392 JP XVIIUltraviolet-visible Reference Spectra

Theophylline

Thiamine Chloride Hydrochloride

Thiamylal Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23932393JP XVII Ultraviolet-visible Reference Spectra

Tiapride Hydrochloride

Timepidium Bromide Hydrate

Timolol Maleate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23942394 JP XVIIUltraviolet-visible Reference Spectra

Tinidazole

Tipepidine Hibenzate

Tizanidine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23952395JP XVII Ultraviolet-visible Reference Spectra

Tocopherol Nicotinate

Todralazine Hydrochloride Hydrate

Tofisopam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23962396 JP XVIIUltraviolet-visible Reference Spectra

Tolazamide

Tolnaftate

Tosufloxacin Tosilate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23972397JP XVII Ultraviolet-visible Reference Spectra

Tranilast

Trapidil

Trepibutone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23982398 JP XVIIUltraviolet-visible Reference Spectra

Triamcinolone Acetonide

Triamterene

Trichlormethiazide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23992399JP XVII Ultraviolet-visible Reference Spectra

Trimebutine Maleate

Trimetazidine Hydrochloride

Trimetoquinol Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24002400 JP XVIIUltraviolet-visible Reference Spectra

Troxipide

Tulobuterol

Tulobuterol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24012401JP XVII Ultraviolet-visible Reference Spectra

L-Tyrosine

Ubenimex

Ulinastatin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24022402 JP XVIIUltraviolet-visible Reference Spectra

Urapidil

Valaciclovir Hydrochloride

Valsartan

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24032403JP XVII Ultraviolet-visible Reference Spectra

Vancomycin Hydrochloride

Verapamil Hydrochloride

Vinblastine Sulfate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24042404 JP XVIIUltraviolet-visible Reference Spectra

Vincristine Sulfate

Voriconazole

Warfarin Potassium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24052405JP XVII Ultraviolet-visible Reference Spectra

Zaltoprofen

Zolpidem Tartrate